Ir.biocryst.com

Press Release Details

WebRESEARCH TRIANGLE PARK, N.C., Aug. 25, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the new drug …

Actived: 2 days ago

URL: https://ir.biocryst.com/news-releases/news-release-details/biocryst-announces-acceptance-regulatory-applications-orladeyor

BioCryst Files Peramivir NDA for the Treatment of Influenza

WebBioCryst is seeking an indication as the first i.v. neuraminidase inhibitor approved in the U.S. for the treatment of acute uncomplicated influenza in adults. Peramivir is approved in …

Category:  Health Go Health

Press Releases BioCryst Pharmaceuticals, Inc.

WebBioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones. Feb 26, 2024. Read More. 1. 2. ›.

Category:  Health Go Health

Press Release Details

Web—Significant and sustained reduction in HAE attacks— —Oral, once-daily prophylactic option enables HAE patients to reduce burden of therapy 1 — …

Category:  Health Go Health

Press Release Details

WebRESEARCH TRIANGLE PARK, N.C., May 12, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the United …

Category:  Health Go Health

Press Release Details

Web— Neopharm Ltd. selected as exclusive distribution and supply partner of ORLADEYO in Israel — RESEARCH TRIANGLE PARK, N.C., June 16, 2021 (GLOBE …

Category:  Health Go Health

BioCryst Provides Update on Galidesivir Program

WebBased on the company’s ongoing discussions with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, a major …

Category:  Health Go Health

BioCryst Receives Health Canada Approval for RAPIVAB® for the …

WebRESEARCH TRIANGLE PARK, N.C., Jan. 08, 2017 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a pharmaceutical company focused on the …

Category:  Health Go Health

Press Release Details

WebRESEARCH TRIANGLE PARK, N.C., Jan. 22, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Ministry of …

Category:  Health Go Health

Early Access to BioCryst’s Berotralstat Granted for HAE Patients in

WebAccording to the the French Code of Public Health, a cohort ATU is dedicated to high unmet medical needs in serious diseases and covers medicinal …

Category:  Medical Go Health

BioCryst Awarded Contract by the National Institute of Allergy and

WebRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the National Institute of …

Category:  Health Go Health

Press Release Details

WebOn September 26, 2019, the company announced the U.S. Department of Health and Human Services (HHS) had exercised its option to purchase an additional …

Category:  Health Go Health

BIOCRYST AND GREEN CROSS ENTER AGREEMENT TO DEVELOP …

WebThrough agreements with the World Health Organization and UNICEF, Hepavax is available in 60 countries, making it the most widely used hepatitis B vaccine …

Category:  Health Go Health

BioCryst Participates in World Health Organization Consultation on

WebRESEARCH TRIANGLE PARK, N.C., Sept. 4, 2014 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced its participation in a consultation …

Category:  Health Go Health

William P. Sheridan Appointed Chief Medical Officer of BioCryst

WebIn January 2007, the U.S. Department of Health and Human Services (HHS) awarded a $102.6 million, four-year contract to BioCryst to advance development of …

Category:  Health Go Health

BioCryst Receives Additional NIAID Funding to Advance …

WebNIAID, part of the National Institutes of Health, granted an initial award of $5.0 million to BioCryst in September 2013. The total funding could be up to $22.0 million …

Category:  Health Go Health

BioCryst Appoints Helen Thackray, M.D., as Chief Research and

WebRESEARCH TRIANGLE PARK, N.C., March 19, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company …

Category:  Health Go Health

BioCryst Receives Additional NIAID Funding to Advance …

WebThis project is substantially funded with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of …

Category:  Health Go Health

BIOCRYST SCHEDULED TO PRESENT AT TWO UPCOMING HEALTH …

WebBioCryst Scheduled to Present at Two Upcoming Health Care Conferences. Birmingham, Alabama - February 23, 2005 - BioCryst Pharmaceuticals, Inc. (Nasdaq …

Category:  Health Go Health

Press Release Details

WebHe organized the global health economics and outcomes research function, supervised product development team leaders and led several clinical development …

Category:  Health Go Health

6th Annual Evercore ISI HealthCONx Conference BioCryst

Web6th Annual Evercore ISI HealthCONx Conference. Nov 28, 2023 9:35 AM EST. View Webcast. Contact Investor Relations. [email protected]

Category:  Health Go Health